pI: 8.859 |
Length (AA): 351 |
MW (Da): 40113 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 291 | 4bgq (A) | 10 | 298 | 60.00 | 0 | 1 | 1.52856 | -0.93 |
2 | 294 | 4agu (A) | 2 | 291 | 48.00 | 0 | 1 | 1.43896 | -0.94 |
2 | 351 | 4ysj (A) | 26 | 351 | 29.00 | 0 | 1 | 1.19585 | -0.05 |
2 | 36 | 3hzt (A) | 74 | 108 | 46.00 | 0 | 0.97 | 0.585415 | 0.15 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 merozoite, ME49 Oocyst. | Hehl AB Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | VEG Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_128030)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_15925 | serine/threonine-protein kinase |
Caenorhabditis elegans | CELE_Y42A5A.4 | Protein Y42A5A.4, isoform A |
Cryptosporidium hominis | Chro.80358 | serine/threonine protein kinase KKIALRE (EC 2.7.1.-) |
Cryptosporidium parvum | cgd8_3070 | serine/threonine protein kinase KKIALRE |
Drosophila melanogaster | Dmel_CG7236 | CG7236 gene product from transcript CG7236-RE |
Echinococcus granulosus | EgrG_001184700 | cyclin dependent kinase 1 |
Echinococcus granulosus | EgrG_000413300 | cyclin dependent kinase 1 |
Echinococcus multilocularis | EmuJ_001184700 | cyclin dependent kinase 1 |
Echinococcus multilocularis | EmuJ_000413300 | cyclin dependent kinase 1 |
Giardia lamblia | GL50803_96616 | Kinase, CMGC CDKL |
Homo sapiens | ENSG00000205111 | cyclin-dependent kinase-like 4 |
Homo sapiens | ENSG00000100490 | cyclin-dependent kinase-like 1 (CDC2-related kinase) |
Homo sapiens | 8999 | cyclin-dependent kinase-like 2 (CDC2-related kinase) |
Homo sapiens | ENSG00000008086 | cyclin-dependent kinase-like 5 |
Leishmania braziliensis | LbrM.32.3540 | mitogen-activated protein kinase, putative,kinase, putative |
Leishmania donovani | LdBPK_323450.1 | mitogen-activated protein kinase, putative |
Leishmania infantum | LinJ.32.3450 | mitogen-activated protein kinase, putative,kinase, putative |
Leishmania major | LmjF.32.3250 | mitogen-activated protein kinase, putative,kinase, putative |
Leishmania mexicana | LmxM.31.3250 | mitogen-activated protein kinase, putative,kinase, putative |
Mus musculus | ENSMUSG00000031292 | cyclin-dependent kinase-like 5 |
Mus musculus | ENSMUSG00000033966 | cyclin-dependent kinase-like 4 |
Mus musculus | ENSMUSG00000020990 | cyclin-dependent kinase-like 1 (CDC2-related kinase) |
Mus musculus | ENSMUSG00000029403 | cyclin-dependent kinase-like 2 (CDC2-related kinase) |
Neospora caninum | NCLIV_015030 | cyclin-dependent kinase-like 5, putative |
Onchocerca volvulus | OVOC6227 |
|
Schistosoma japonicum | Sjp_0130070 | Cyclin-dependent kinase-like 2, putative |
Schistosoma japonicum | Sjp_0121530 | Cyclin-dependent kinase-like 2, putative |
Schistosoma japonicum | Sjp_0131230 | Cyclin-dependent kinase-like 1, putative |
Schistosoma japonicum | Sjp_0091160 | expressed protein |
Schistosoma japonicum | Sjp_0000210 | ko:K08824 cyclin-dependent kinase-like, putative |
Schistosoma japonicum | Sjp_0083310 | Cyclin-dependent kinase-like 2, putative |
Schistosoma japonicum | Sjp_0091150 | Cyclin-dependent kinase-like 1, putative |
Schistosoma mansoni | Smp_157240 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_124130 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_163380 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.001129.02 | Cyclin-dependent kinase-like 1 |
Schmidtea mediterranea | mk4.001129.09 | |
Schmidtea mediterranea | mk4.004836.00 | Cyclin-dependent kinase-like 1 |
Schmidtea mediterranea | mk4.005480.01 | Cyclin-dependent kinase-like 3 |
Schmidtea mediterranea | mk4.006047.02 | Cyclin-dependent kinase-like 1 |
Schmidtea mediterranea | mk4.006699.02 | Cyclin-dependent kinase-like 3 |
Schmidtea mediterranea | mk4.006699.01 | Cyclin-dependent kinase-like 3 |
Schmidtea mediterranea | mk4.005480.00 | Cyclin-dependent kinase-like 2 |
Trypanosoma brucei gambiense | Tbg972.11.18950 | protein kinase, putative |
Trypanosoma brucei | Tb927.11.16790 | mitogen-activated protein kinase |
Trypanosoma congolense | TcIL3000.11.16750 | mitogen-activated protein kinase |
Trypanosoma cruzi | TcCLB.511531.59 | mitogen activated protein kinase, putative |
Trypanosoma cruzi | TcCLB.511025.30 | mitogen-activated protein kinase, putative |
Toxoplasma gondii | TGME49_285160 | cyclin-dependent kinase family 5 protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.8550 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.8550 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.8550 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.8550 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_285160 this record | Toxoplasma gondii | Probably non-essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | cyclin-dependent kinase-like 1 (CDC2-related kinase) | Compounds | References |
Homo sapiens | cyclin-dependent kinase-like 5 | Compounds | References |
Homo sapiens | cyclin-dependent kinase-like 2 (CDC2-related kinase) | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 40.7% | 172 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 39.5% | 299 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 37.8% | 304 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 39.1% | 302 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 31.5% | 308 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 39.1% | 297 aa | Compounds | References |